
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Accumulated cholesterol protects tumours from elevated lipid peroxidation in the microenvironment
Xi Zhao, Xinyu Lian, Jianlan Xie, et al.
Redox Biology (2023) Vol. 62, pp. 102678-102678
Open Access | Times Cited: 45
Xi Zhao, Xinyu Lian, Jianlan Xie, et al.
Redox Biology (2023) Vol. 62, pp. 102678-102678
Open Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Ferroptosis: principles and significance in health and disease
Fangquan Chen, Rui Kang, Daolin Tang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 51
Fangquan Chen, Rui Kang, Daolin Tang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 51
Metabolism-regulated ferroptosis in cancer progression and therapy
Lvlan Ye, Xiangqiong Wen, Jiale Qin, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 25
Lvlan Ye, Xiangqiong Wen, Jiale Qin, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 25
Lipid Peroxidation Drives Liquid–Liquid Phase Separation and Disrupts Raft Protein Partitioning in Biological Membranes
Muthuraj Balakrishnan, Anne K. Kenworthy
Journal of the American Chemical Society (2024) Vol. 146, Iss. 2, pp. 1374-1387
Open Access | Times Cited: 21
Muthuraj Balakrishnan, Anne K. Kenworthy
Journal of the American Chemical Society (2024) Vol. 146, Iss. 2, pp. 1374-1387
Open Access | Times Cited: 21
Cholesterol metabolism in tumor immunity: Mechanisms and therapeutic opportunities for cancer
Xiaojia Guo, Bobo Zhu, Jing Li, et al.
Biochemical Pharmacology (2025), pp. 116802-116802
Closed Access | Times Cited: 2
Xiaojia Guo, Bobo Zhu, Jing Li, et al.
Biochemical Pharmacology (2025), pp. 116802-116802
Closed Access | Times Cited: 2
Lipid peroxidation: Reactive carbonyl species, protein/DNA adducts, and signaling switches in oxidative stress and cancer
Nurbubu T. Moldogazieva, S. P. Zavadskiy, Dmitry V. Astakhov, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 687, pp. 149167-149167
Closed Access | Times Cited: 28
Nurbubu T. Moldogazieva, S. P. Zavadskiy, Dmitry V. Astakhov, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 687, pp. 149167-149167
Closed Access | Times Cited: 28
Cholesterol mediated ferroptosis suppression reveals essential roles of Coenzyme Q and squalene
Qi Sun, Diming Liu, Weiwei Cui, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 23
Qi Sun, Diming Liu, Weiwei Cui, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 23
Cell Membrane‐Targeting Type I/II Photodynamic Therapy Combination with FSP1 Inhibition for Ferroptosis‐Enhanced Photodynamic Immunotherapy
Jian Chen, Zeyu Duan, Lidong Deng, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 16
Closed Access | Times Cited: 11
Jian Chen, Zeyu Duan, Lidong Deng, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 16
Closed Access | Times Cited: 11
Current Progress of Ferroptosis Study in Hepatocellular Carcinoma
Xinyue Zhu, Xudong Sha, Yan Zang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3621-3637
Open Access | Times Cited: 11
Xinyue Zhu, Xudong Sha, Yan Zang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3621-3637
Open Access | Times Cited: 11
Nanoparticle Targeting in Chemo‐Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance
Yinu Wang, Andrea E. Calvert, Horacio Cárdenas, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 9
Yinu Wang, Andrea E. Calvert, Horacio Cárdenas, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 9
Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity
Liming Gui, Kaiwen W. Chen, Jingjing Yan, et al.
Cell Reports Medicine (2025), pp. 101913-101913
Open Access | Times Cited: 1
Liming Gui, Kaiwen W. Chen, Jingjing Yan, et al.
Cell Reports Medicine (2025), pp. 101913-101913
Open Access | Times Cited: 1
RETRACTED: Physicochemical characterization, in vitro and in vivo evaluation of chitosan/carrageenan encumbered with Imatinib mesylate-polysarcosine nanoparticles for sustained drug release and enhanced colorectal cancer targeted therapy
Sankha Bhattacharya, Smita Bonde, Ketan Hatware, et al.
International Journal of Biological Macromolecules (2023) Vol. 245, pp. 125529-125529
Closed Access | Times Cited: 20
Sankha Bhattacharya, Smita Bonde, Ketan Hatware, et al.
International Journal of Biological Macromolecules (2023) Vol. 245, pp. 125529-125529
Closed Access | Times Cited: 20
ALOX15B controls macrophage cholesterol homeostasis via lipid peroxidation, ERK1/2 and SREBP2
Yvonne Benatzy, Megan A. Palmer, Dieter Lütjohann, et al.
Redox Biology (2024) Vol. 72, pp. 103149-103149
Open Access | Times Cited: 7
Yvonne Benatzy, Megan A. Palmer, Dieter Lütjohann, et al.
Redox Biology (2024) Vol. 72, pp. 103149-103149
Open Access | Times Cited: 7
Analyzing the impact of metabolism on immune cells in tumor microenvironment to promote the development of immunotherapy
Yanru Long, Houhui Shi, Yuedong He, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
Yanru Long, Houhui Shi, Yuedong He, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
Cholesterol-ferroptosis nexus: Unveiling novel cancer therapeutic avenues
Jaewang Lee, Jong‐Lyel Roh
Cancer Letters (2024) Vol. 597, pp. 217046-217046
Closed Access | Times Cited: 6
Jaewang Lee, Jong‐Lyel Roh
Cancer Letters (2024) Vol. 597, pp. 217046-217046
Closed Access | Times Cited: 6
Cholesterol Depletion‐Enhanced Ferroptosis and Immunotherapy via Engineered Nanozyme
Tingjie Bai, P. Xue, Sijie Shao, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 6
Tingjie Bai, P. Xue, Sijie Shao, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 6
Celastrol functions as an emerging manager of lipid metabolism: Mechanism and therapeutic potential
Jia Gu, Yaning Shi, Neng Zhu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114981-114981
Open Access | Times Cited: 16
Jia Gu, Yaning Shi, Neng Zhu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114981-114981
Open Access | Times Cited: 16
Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy
Hongyan Zhang, Yujie Li, Jingyi Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4717-4737
Open Access | Times Cited: 5
Hongyan Zhang, Yujie Li, Jingyi Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4717-4737
Open Access | Times Cited: 5
Inhibition of PCSK9: a promising enhancer for anti-PD-1/PD-L1 immunotherapy
Shengbo Sun, Jingxin Ma, Tingting Zuo, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 5
Shengbo Sun, Jingxin Ma, Tingting Zuo, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 5
Emerging Roles of Nanozyme in Tumor Metabolism Regulation: Mechanisms, Applications, and Future Directions
You Li, Bowen Fu, Wei Jiang
ACS Applied Materials & Interfaces (2025)
Closed Access
You Li, Bowen Fu, Wei Jiang
ACS Applied Materials & Interfaces (2025)
Closed Access
Fangchinoline suppresses nasopharyngeal carcinoma progression by inhibiting SQLE to regulate the PI3K/AKT pathway dysregulation
Jieyun Xie, Zheng-Zheng Shi, Lingling Sun, et al.
Phytomedicine (2025) Vol. 140, pp. 156484-156484
Open Access
Jieyun Xie, Zheng-Zheng Shi, Lingling Sun, et al.
Phytomedicine (2025) Vol. 140, pp. 156484-156484
Open Access
LRRK2 reduces the sensitivity to TKI and PD-1 blockade in ccRCC via activating LPCAT1
Yulong Hong, Weidong Li, Zhuo Xing, et al.
Oncogene (2025)
Closed Access
Yulong Hong, Weidong Li, Zhuo Xing, et al.
Oncogene (2025)
Closed Access
Unveiling the crossroads of STING signaling pathway and metabolic reprogramming: the multifaceted role of the STING in the TME and new prospects in cancer therapies
Siwei Wang, Qin Lu, Furong Liu, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Siwei Wang, Qin Lu, Furong Liu, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Cholesterol effects on the tumor immune microenvironment: from fundamental concepts to mechanisms and implications
Francisco Alejandro Lagunas‐Rangel
Frontiers in Oncology (2025) Vol. 15
Open Access
Francisco Alejandro Lagunas‐Rangel
Frontiers in Oncology (2025) Vol. 15
Open Access
Lipid rafts: novel therapeutic targets for metabolic, neurodegenerative, oncological, and cardiovascular diseases
Mohamad Warda, Samet Tekin, Mahmoud Gamal, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Mohamad Warda, Samet Tekin, Mahmoud Gamal, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
A biphasic nanoplatform with switchable biochemical programs for combined organelle-specific cancer therapy
Wanting Hao, Meng Zhang, R. Li, et al.
Chemical Engineering Journal (2025), pp. 163057-163057
Closed Access
Wanting Hao, Meng Zhang, R. Li, et al.
Chemical Engineering Journal (2025), pp. 163057-163057
Closed Access